A. Neiss

发表

Analysing the course of multiple sclerosis with segmented regression models

M. Daumer, B. Hellriegel, A. Neiss, 2003 .

Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events including Physicians' Experience and Evaluation)

G. Assmann, P. Cullen, H. Schulte, 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Effects of varicella vaccination on herpes zoster incidence.

S. Wagenpfeil, P. Wutzler, A. Neiss, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

M. Gahr, H. Schmitt, W. Rauh, 1996, JAMA.

[Acrylonitrile--epidemiological study--Bayer 1977: a report on a prospective epidemiological study with a past beginning of coworkers at the Leverkusen plant of Bayer AG with acrylonitrile (ACN) exposure].

T. Zwingers, A. Neiss, H. J. Lange, 1979, Zentralblatt fur Arbeitsmedizin, Arbeitsschutz und Prophylaxe.

23 ELSA, European Lacidipine Study on Atherosclerosis

G. Mancia, A. Zanchetti, M. Safar, 1993 .

The E.L.S.A. Trial: Protocol of a Randomized Trial to Explore the Differential Effect of Antihypertensive Drugs on Atherosclerosis in Hypertension

G. Mancia, A. Zanchetti, M. Safar, 1994, Journal of cardiovascular pharmacology.

S25.1: Alternative designs for phase II MS trials

Susanne Menzler, Martin Daumer, Helmut Küchenhoff, 2004 .

Acellular pertussis vaccines: the rationale for an efficacy trial in Germany.

M. Knuf, H. Schmitt, H. Bock, 1996, The Journal of infectious diseases.

The cost-effectiveness of routine childhood varicella vaccination in Germany.

P Wutzler, S. Wagenpfeil, P. Wutzler, 2003, Vaccine.

Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany

P. Wutzler, A. Neiss, K. Banz, 2002, Medical Microbiology and Immunology.

Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature

S. Wagenpfeil, P. Wutzler, A. Neiss, 2004, PharmacoEconomics.

[Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].

M. Knuf, P. Wutzler, A. Neiss, 2006, Klinische Padiatrie.

Withdrawal of a mumps vaccine: Reasons and impacts

H. Schmitt, A. Neiss, M. Just, 1993, European Journal of Pediatrics.

Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

G. Mancia, A. Zanchetti, M. Bond, 2002, Circulation.

The influence of measles vaccination on the incidence of otosclerosis in Germany

W. Arnold, R. Busch, A. Neiss, 2007, European Archives of Oto-Rhino-Laryngology.

Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis

Giuseppe Mancia, G. Mancia, A. Zanchetti, 1998, Journal of hypertension.

Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.

A E Fletcher, C. Bulpitt, C. Furberg, 1992, Hypertension.

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.

T. Lenarz, M. Hennig, W. Arnold, 2001, European journal of cancer.

Empirical data on the varicella situation in Germany for vaccination decisions.

P Wutzler, S. Wagenpfeil, P. Wutzler, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.

D. Back, S. Ward, E. Daume, 1993, Contraception.

Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).

G. Breithardt, E. Fleck, A. von Eckardstein, 1999, European heart journal.

The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).

H. Wieland, L. Kappenberger, P. Betz, 1997, European heart journal.

[Antiarrhythmic drugs in chronic ventricular extrasystole (author's transl)].

A. Neiss, J. Schlegel, A. Wirtzfeld, 2008, Deutsche medizinische Wochenschrift.

Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial).

W. März, H. Wollschläger, M. Wehling, 1999, The American journal of cardiology.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns.

W. März, H. Wollschläger, M. Wehling, 2002, Preventive medicine.

The burden of varicella in Germany

S. Wagenpfeil, P. Wutzler, A. Neiss, 2004, The European Journal of Health Economics, formerly: HEPAC.

Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis

L. Kappos, C. Polman, C. Lederer, 2006, Neurology.

Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker.

E. Frohlich, P. Baumgart, A. Neiss, 1996, Cardiology.

[MS registry in Germany--design and first results of the pilot phase].

M. Daumer, P. Rieckmann, U. Zettl, 2005, Der Nervenarzt.

Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany--results from the CODE-2 study.

H Stammer, B. Wieseler, A. Liebl, 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Validation of health economic models: the example of EVITA.

Stefan Wagenpfeil, Peter Wutzler, S. Wagenpfeil, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The burden of varicella in Germany. Potential risks and economic impact.

S. Wagenpfeil, P. Wutzler, A. Neiss, 2004, The European journal of health economics : HEPAC : health economics in prevention and care.

Observer Bias in Acellular Pertussis Vaccine Trials

H. Schmitt, A. Neiss, C. W. von König, 1999, Pediatrics.

[Post-infarction ventricular function in relation to the contractility of the remaining myocardium (author's transl)].

W. Baxley, W. Delius, H. Sebening, 1979, Deutsche medizinische Wochenschrift.

[Costs of type 2 diabetes in Germany. Results of the CODE-2 study].

A. Liebl, A. Neiss, U. Reitberger, 2001, Deutsche medizinische Wochenschrift.

Kosten des Typ-2-Diabetes in Deutschland

A. Liebl, A. Neiss, U. Reitberger, 2001 .

Pharmacokinetics and protein binding of 3-ketodesogestrel and gestodene in the serum of women during 6 cycles of treatment with two low dose oral contraceptives

D. Back, E. Daume, A. Neiss, 1993, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

Treating Systematic Errors in Multiple Sclerosis Data

L. Kappos, C. Polman, S. Vukusic, 2005 .

MS-Register in Deutschland — Design und erste Ergebnisse der Pilotphase

M. Daumer, U. Götze, S. Schimrigk, 2005, Der Nervenarzt.

[Costs of type 2 diabetes in Germany. Results of the CODE-2 study].

A. Liebl, A. Neiss, U. Reitberger, 2001, Deutsche medizinische Wochenschrift.